Literature DB >> 26032554

Kidney cancer: Carbonic anhydrase IX in resected clear cell RCC.

Lisa M Pickering1, James Larkin2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26032554     DOI: 10.1038/nrurol.2015.124

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  6 in total

1.  Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial.

Authors:  Karim Chamie; Pia Klöpfer; Paul Bevan; Stephan Störkel; Jonathan Said; Barbara Fall; Arie S Belldegrun; Allan J Pantuck
Journal:  Urol Oncol       Date:  2015-03-29       Impact factor: 3.498

2.  Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

Authors:  Michael Atkins; Meredith Regan; David McDermott; James Mier; Eric Stanbridge; Amanda Youmans; Philip Febbo; Melissa Upton; Mirna Lechpammer; Sabina Signoretti
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

3.  Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

Authors:  Matthew H T Bui; David Seligson; Ken-ryu Han; Allan J Pantuck; Frederick J Dorey; Yunda Huang; Steve Horvath; Bradley C Leibovich; Shefali Chopra; Shu-Yuan Liao; Eric Stanbridge; Michael I Lerman; Aarno Palotie; Robert A Figlin; Arie S Belldegrun
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

4.  Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.

Authors:  Bradley C Leibovich; Yuri Sheinin; Christine M Lohse; R Houston Thompson; John C Cheville; Jan Zavada; Eugene D Kwon
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

5.  Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.

Authors:  Ben Y Zhang; R Houston Thompson; Christine M Lohse; Roxana S Dronca; John C Cheville; Eugene D Kwon; Bradley C Leibovich
Journal:  BJU Int       Date:  2013-04-02       Impact factor: 5.588

6.  Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Igor Frank; Eugene D Kwon; Amy L Weaver; Alexander S Parker; Horst Zincke
Journal:  Cancer       Date:  2003-04-01       Impact factor: 6.860

  6 in total
  4 in total

1.  Carbonic Anhydrase VIII (CAVIII) Gene Mediated Colorectal Cancer Growth and Angiogenesis through Mediated miRNA 16-5p.

Authors:  Mingli Hsieh; Pei-Ju Huang; Pei-Yu Chou; Shih-Wei Wang; Hsi-Chi Lu; Wei-Wen Su; Yuan-Chiang Chung; Min-Huan Wu
Journal:  Biomedicines       Date:  2022-04-29

2.  Clear cell adenocarcinoma presenting as acute pancreatitis: A rare form of primary pancreatic malignancy.

Authors:  Robert S O'Neill; Lyn L Lam; Parthsinh Solanki; Robyn Levingston; David Thomas
Journal:  Cancer Rep (Hoboken)       Date:  2020-08-09

3.  Primary clear cell adenocarcinoma of the pancreas: a case report and literature update.

Authors:  Pi-Jiang Sun; Yan-Hua Yu; Xi-Jun Cui
Journal:  Onco Targets Ther       Date:  2018-11-16       Impact factor: 4.147

4.  Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma.

Authors:  Joon Chae Na; Jee-Hoon Kim; Sook Young Kim; Young-Ran Gu; Dae-Young Jun; Hyung Ho Lee; Young Eun Yoon; Kyung Hwa Choi; Sung Joon Hong; Woong Kyu Han
Journal:  Investig Clin Urol       Date:  2020-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.